PRESCRIPTION DRUG PRICING BY HOSPITAL PHARMACIES - PRELIMINARY STUDY

被引：5
|
作者：
SILVERMAN, M
LYDECKER, M
机构：
[1] UNIV CALIF, SCH MED, HLTH POLICY PROGRAM, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF, SCH PHARM, SAN FRANCISCO, CA 94143 USA
来源：
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1974年 / 31卷 / 09期
关键词：
D O I：
10.1093/ajhp/31.9.870
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：870 / 875
页数：6
相关论文
共 50 条
  • [31] Does bargaining affect Medicare prescription drug plan reimbursements to independent pharmacies?
    Tang, Yuexin
    Xie, Yang
    Urmie, Julie M.
    Doucette, William R.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2011, 51 (06) : 738 - U84
  • [32] Preventing drug interactions by online prescription screening in community pharmacies and medical practices
    Halkin, H
    Katzir, I
    Kurman, I
    Jan, J
    Malkin, BBO
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 260 - 265
  • [33] Drug shortages in retail pharmacies: which economic impact, management difficulties and challenges for hospital pharmacies?
    Boczek, C.
    Vigier, C.
    Jacob, C.
    Dumas, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1263 - 1264
  • [34] A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital
    Kulkarni, Vijay
    Bora, Swathi Swaroopa
    Sirisha, Sapineni
    Saji, Mohammed
    Sundaran, Siraj
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2013, 4 (04) : 141 - 146
  • [35] An observational study of the cause and frequency of prescription rework in community pharmacies
    Frank Olden
    Kieran Dalton
    International Journal of Clinical Pharmacy, 2023, 45 : 903 - 912
  • [36] An observational study of the cause and frequency of prescription rework in community pharmacies
    Olden, Frank
    Dalton, Kieran
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (04) : 903 - 912
  • [37] Availability of pharmacies participating in the 340B Drug Pricing Program, 2016
    Guadamuz, Jenny S.
    Qato, Dima M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 429 - 430
  • [38] AVAILABILITY OF PHARMACIES PARTICIPATING IN THE 340B DRUG PRICING PROGRAM, 2016
    Guadamuz, J.
    Qato, D.
    VALUE IN HEALTH, 2018, 21 : S97 - S97
  • [39] New Reforms to Prescription Drug Pricing in the US Opportunities and Challenges
    Hwang, Thomas J.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (11): : 1041 - 1042
  • [40] Authorized Generics and Their Evolving Role in Prescription Drug Pricing and Access
    Dusetzina, Stacie B.
    Keating, Nancy L.
    Huskamp, Haiden A.
    JAMA INTERNAL MEDICINE, 2021, 181 (04) : 423 - 424
12345